Skip to main content
Inventiva logo

Inventiva — Investor Relations & Filings

Ticker · IVA ISIN · FR0013233012 LEI · 969500I9Y690B3FZW590 PA Manufacturing
Open in API
Filings indexed 686 across all filing types
Latest filing 2025-11-17 Capital/Financing Update
Country FR France
Listing PA IVA

About Inventiva

https://inventivapharma.com/

Inventiva is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for diseases with significant unmet medical needs. The company's primary therapeutic areas include fibrotic diseases, lysosomal storage disorders, and oncology. Its lead product candidate, lanifibranor, is a pan-PPAR (peroxisome proliferator-activated receptor) agonist being evaluated in a pivotal Phase III clinical trial for the treatment of non-alcoholic steatohepatitis (NASH). Lanifibranor is designed to address the key features of NASH, including steatosis, inflammation, ballooning, and fibrosis. The candidate has received Breakthrough Therapy Designation from the U.S. Food and Drug Administration (FDA) based on positive Phase IIb results.

Recent filings

Filing Released Lang Actions
Inventiva annonce l’exercice intégral de l’Option des Banques portant le montant de l'Offre à environ 172,5 millions de dollars
Capital/Financing Update Classification · 100% confidence The document is a press release from Inventiva announcing the full exercise of an 'over-allotment option' (Option des Banques) related to a previously announced public offering of American Depositary Shares (ADSs). It details the financial proceeds, the number of shares issued, and the intended use of funds. This falls under the category of capital raising and financing activities. It is not a report itself, but an announcement of a transaction, fitting the 'Capital/Financing Update' category.
2025-11-17 French
Inventiva announces full exercise of Underwriters’ Option, bringing proceeds of Offering to approximately $172.5M
Capital/Financing Update Classification · 100% confidence The document is a press release announcing the full exercise of an underwriters' option following a public offering of American Depositary Shares (ADSs). It details the financial proceeds, the offering price, and the regulatory context of the transaction. This falls under the category of capital and financing updates, as it describes the finalization of a fundraising event and changes to the company's capital structure.
2025-11-17 English
Inventiva annonce la reprise des négociations de ses actions ordinaires sur Euronext Paris
Capital/Financing Update Classification · 95% confidence The document is a press release from Inventiva announcing the resumption of trading of its ordinary shares on Euronext Paris following a temporary suspension related to a public offering of American Depositary Shares (ADS). This document describes a specific corporate financing event (the offering) and the resulting market action (trading suspension and resumption). According to the filing definitions, this falls under 'Capital/Financing Update' (CAP) as it pertains to financing activities and capital structure changes.
2025-11-13 French
Inventiva announces trading resumption of its ordinary shares on Euronext Paris
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the resumption of trading of Inventiva's shares on Euronext Paris following a public offering. It details the context of the trading halt (the offering) and the subsequent resumption. This falls under capital/financing updates as it relates to the company's public offering and market activity regarding its shares.
2025-11-13 English
Inventiva annonce les modalités définitives ainsi que l'extension de l'offre au public d'American Depositary Shares d'approximativement 150 millions de dollars
Capital/Financing Update Classification · 100% confidence The document is a press release from Inventiva announcing the final terms and pricing of a public offering of American Depositary Shares (ADSs) to raise approximately $150 million. It details the subscription price, the use of proceeds, the impact on share capital, and the involvement of underwriters. This falls under the category of capital raising and financing activities.
2025-11-13 French
Inventiva announces pricing of upsized public offering of approximately $150M of American Depositary Shares
Capital/Financing Update Classification · 100% confidence The document is a press release announcing the pricing of a public offering of American Depositary Shares (ADSs) to raise approximately $150 million. It details the offering price, the use of proceeds, the impact on share capital, and the underwriting arrangements. This falls squarely under the definition of a Capital/Financing Update (CAP), as it describes a specific fundraising activity and changes to the company's capital structure.
2025-11-13 English

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.